ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Zinder Report Asks VCP To Switch Most Research To Grants, Spread Work Among More Scientists, Change Review Groups

March 22, 1974

Pancreatic Lesions Related To Corn Oil Status Reports Made

March 25, 1983

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003

Board Commends M.D. Anderson On 50th Year

May 17, 1991

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003